Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Alps Medical Breakthroughs ETF (SBIO)

40.91   0.25 (0.61%) 09-28 23:24
Open: 41 Pre. Close: 40.66
High: 40.9025 Low: 40.51
Volume: 12,648 Market Cap: 0M
SBIO was created on 12/31/14 by SS&C. The ETF tracks the Poliwogg Medical Breakthroughs Index, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 41.038 - 41.196 41.196 - 41.377
Low: 40.075 - 40.247 40.247 - 40.444
Close: 40.541 - 40.816 40.816 - 41.133

Technical analysis

as of: 2020-09-28 4:37:09 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 49.70     One year: 58.05
Support: Support1: 39.24    Support2: 37.20
Resistance: Resistance1: 42.55    Resistance2: 49.70
Pivot: 40.45
Moving Average: MA(5): 40.52     MA(20): 40.31
MA(100): 41.44     MA(250): 39.03
MACD: MACD(12,26): -0.03     Signal(9): -0.09
Stochastic oscillator: %K(14,3): 58.76     %D(3): 57.92
RSI: RSI(14): 50.99
52-week: High: 45.02  Low: 25.10  Change(%): 32.7
Average Vol(K): 3-Month: 2325  10-Days: 1332

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
SBIO has closed below upper band by 41.8%. Bollinger Bands are 30.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 15 Sep 2020
Biotech ETFs Soar on Gilead-Immunomedics Deal - Yahoo Finance

Tue, 25 Aug 2020
Acquisitions & Postive Drug Data Boost SBIO ETF Again - ETF Trends

Mon, 03 Aug 2020
When Innovation and Being Nimble Matters, Turn to this Biotech ETF - ETF Trends

Fri, 31 Jul 2020
Betting on Biotech With Utility Beyond Covid-19 - ETF Trends

Tue, 07 Jul 2020
Fabulous Fundamentals Brighten Outlook for Healthcare, With This Biotech ETF - ETF Trends

Thu, 02 Jul 2020
3 High Growth Biotech ETFs For 2020 - TheStreet

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Shares Out. (M)
Shares Float (M) 7
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.